1H-Imidazo[4,5-c]quinoline derivatives as novel potent TNF-α suppressors: synthesis and structure–activity relationship of 1-, 2-and 4-substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines
- 12 June 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (12) , 2541-2550
- https://doi.org/10.1016/s0968-0896(03)00178-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptArthritis & Rheumatism, 2002
- Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%Antiviral Research, 1999
- ImiquimodDrugs of Today, 1999
- Topical ImiquimodDrugs, 1999
- The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid ArthritisDrugs, 1998
- INDUCTION OF CYTOKINES IN CYNOMOLGUS MONKEYS BY THE IMMUNE RESPONSE MODIFIERS, IMIQUIMOD, S-27609 AND S-28463Cytokine, 1997
- Cytokines in autoimmunityCurrent Opinion in Immunology, 1996
- Initiation of acute phase response and synthesis of cytokinesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseasesCurrent Opinion in Immunology, 1991
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975